Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 82 for

Edit search filters
  1. A Multiple Dose Study To Evaluate Safety, Tolerability, PK, And Efficacy Of SER-155 In Adults Undergoing HSCT

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Study For The Treatment Of Cytomegalovirus (CMV) Infection In Hematopoietic Stem Cell Transplant Recipients

    Rochester, MN

  3. A Study Of Siremadlin Alone And In Combination With Donor Lymphocyte Infusion In Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

    Jacksonville, FL

  4. A Study of a Wearable Vital Signs Monitoring Device for the Detection of Systemic Inflammatory Response Syndrome and Sepsis in Stem Cell Transplant Patients

    Scottsdale/Phoenix, AZ

  5. Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant For Multiple Sclerosis (BEAT-MS)

    Rochester, MN

  6. A Study To Evaluate Itacitinib For Low Risk Graft-vs-Host Disease (GVHD)

    Rochester, MN

  7. A Study To Evaluate Ruxolitinib For The Treatment Of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

    Scottsdale/Phoenix, AZ

  8. A Study To Evaluate Tacrolimus/Methotrexate Versus Post-Transplant Cyclophosphamide/ Tacrolimus/Mycophenolate Mofetil In Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

    Jacksonville, FL, Rochester, MN

  9. GRAVITAS-301: A Study Of Itacitinib Or Placebo In Combination With Corticosteroids For Treatment Of Acute Graft-Versus-Host Disease

    Rochester, MN

  10. A Study Of Ibrutinib As Prophylaxis For Chronic Graft-Versus-Host Disease (GVHD) In Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

    Jacksonville, FL

.

Mayo Clinic Footer